Diagnosis Confirmation
Several tests are available to test for B. pertussis. Culture is considered the gold standard because it is the only 100% specific method for identification. Other tests that can be performed include polymerase chain reaction (PCR) and serology.
Culture
Since culture is considered the gold standard, it is particularly important to isolate the bacterium and confirm the pertussis diagnosis if an outbreak is suspected. Many other respiratory pathogens have similar clinical symptoms to pertussis and co-infections are common. Culture will help identify strains of Bordetella pertussis. Identifying which strains of Bordetella pertussis are causing disease is of public health importance. Culture is best done from nasopharyngeal (NP) specimens collected during the first 2 weeks of cough when viable bacteria are still present in the nasopharynx.
Key Resource
PCR
PCR allows for confirmation and speciation among Bordetella species. Results should be interpreted along with the clinical symptoms and epidemiological information. PCR tests vary in specificity, so obtaining culture confirmation of pertussis for at least one suspicious case is recommended any time there is suspicion of a pertussis outbreak. PCR should ideally be tested from NP specimens taken at 0-3 weeks following cough onset, but may provide accurate results for up to 4 weeks of cough in infants or unvaccinated persons. After the fourth week of cough, the amount of bacterial DNA rapidly diminishes, which increases the risk of obtaining falsely-negative results.
Serology
Serologic assays can be useful for confirming diagnosis, especially during suspected outbreaks. There are many different serologic tests used in laboratories. Generally, serologic tests are more useful for diagnosis in later phases of the disease. For a single point serology, the optimal timing for specimen collection is 2 to 8 weeks following cough onset, when the antibody titers are at their highest; however, serology may be performed on specimens collected up to 12 weeks following cough onset.

For more information, see the Pertussis Laboratory Information page or the Pertussis Laboratory Testing section of the Manual for the Surveillance of Vaccine-Preventable Diseases.
Images and logos on this website which are trademarked/copyrighted or used with permission of the trademark/copyright or logo holder are not in the public domain. These images and logos have been licensed for or used with permission in the materials provided on this website. The materials in the form presented on this website may be used without seeking further permission. Any other use of trademarked/copyrighted images or logos requires permission from the trademark/copyright holder...more
This graphic notice means that you are leaving an HHS Web site. For more information, please see the Exit Notification and Disclaimer policy.
Contact Us:
- Centers for Disease Control and Prevention
1600 Clifton Rd
Atlanta, GA 30333 - 800-CDC-INFO
(800-232-4636)
TTY: (888) 232-6348 - New Hours of Operation
8am-8pm ET/Monday-Friday
Closed Holidays - cdcinfo@cdc.gov





